COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aclaris Therapeutics | COMM | 00461U105 | 14,127 | 1,911,573 | SH | | SOLE | | 1,911,573 | 0 | 0 |
Amarin | ADR | 023111206 | 70,885 | 5,208,305 | SH | | SOLE | | 5,208,305 | 0 | 0 |
Apellis Pharmaceuticals, Inc | COMM | 03753U106 | 654 | 49,580 | SH | | SOLE | | 49,580 | 0 | 0 |
Ascendis Pharma A/S | ADR | 04351P101 | 93,883 | 1,498,538 | SH | | SOLE | | 1,498,538 | 0 | 0 |
Audentes Therapeutics | COMM | 05070R104 | 19,905 | 933,640 | SH | | SOLE | | 933,640 | 0 | 0 |
Chiasma | COMM | 16706W102 | 5,070 | 1,630,221 | SH | | SOLE | | 1,630,221 | 0 | 0 |
Coherus BioSciences | COMM | 19249H103 | 25,957 | 2,868,221 | SH | | SOLE | | 2,868,221 | 0 | 0 |
Edge Therapeutics | COMM | 279870109 | 916 | 2,852,711 | SH | | SOLE | | 2,852,711 | 0 | 0 |
Entasis Therapeutics Holdings Inc. | COMM | 293614103 | 4,803 | 1,180,178 | SH | | SOLE | | 1,180,178 | 0 | 0 |
Iterum Therapeutics | COMM | G6333L101 | 8,650 | 1,726,514 | SH | | SOLE | | 1,726,514 | 0 | 0 |
Kiniksa Pharmaceuticals, Ltd | COMM CL A | G5269C101 | 25,919 | 922,700 | SH | | SOLE | | 922,700 | 0 | 0 |
Merus N.V. | COMM | N5749R100 | 27,455 | 1,961,039 | SH | | SOLE | | 1,961,039 | 0 | 0 |
Natera | COMM | 632307104 | 43,284 | 3,100,560 | SH | | SOLE | | 3,100,560 | 0 | 0 |
Nucana Biomed Ltd | ADR | 67022C106 | 32,867 | 2,266,666 | SH | | SOLE | | 2,266,666 | 0 | 0 |
Nucana Biomed Ltd | Ordinary Sh | GB00BYWYV | 34,800 | 2,400,000 | SH | | SOLE | | 2,400,000 | 0 | 0 |
ObsEva SA | COMM | H5861P103 | 60,130 | 4,749,623 | SH | | SOLE | | 4,749,623 | 0 | 0 |
Principia Biopharma | COMM | 74257L108 | 55,827 | 2,038,208 | SH | | SOLE | | 2,038,208 | 0 | 0 |
Spark Therapeutics | COMM | 84652J103 | 18,837 | 481,270 | SH | | SOLE | | 481,270 | 0 | 0 |
Synlogic Inc. (fmrly Mirna) | COMM | 87166L100 | 4,031 | 574,972 | SH | | SOLE | | 574,972 | 0 | 0 |
Y-mAbs Therapeutics, Inc | COMM | 984241109 | 42,801 | 2,104,278 | SH | | SOLE | | 2,104,278 | 0 | 0 |
Aimmune Therapeutics Inc | COMM | 00900T107 | 633 | 26,467 | SH | | SOLE | | 26,467 | 0 | 0 |
Amicus Therapeutics Inc | COMM | 03152W109 | 972 | 101,505 | SH | | SOLE | | 101,505 | 0 | 0 |
AnaptysBio Inc | COMM | 032724106 | 240 | 3,769 | SH | | SOLE | | 3,769 | 0 | 0 |
AstraZeneca PLC | ADR | 046353108 | 1,811 | 47,681 | SH | | SOLE | | 47,681 | 0 | 0 |
Biohaven Pharmaceutical Holding Company Ltd | COMM | G11196105 | 543 | 14,673 | SH | | SOLE | | 14,673 | 0 | 0 |
Biomarin Pharmaceutical Inc | COMM | 09061G101 | 1,804 | 21,184 | SH | | SOLE | | 21,184 | 0 | 0 |
Clovis Oncology Inc | COMM | 189464100 | 778 | 43,342 | SH | | SOLE | | 43,342 | 0 | 0 |
Conatus Pharmaceuticals Inc | COMM | 20600T108 | 166 | 96,139 | SH | | SOLE | | 96,139 | 0 | 0 |
Deciphera Pharmaceuticals Inc | COMM | 24344T101 | 839 | 39,992 | SH | | SOLE | | 39,992 | 0 | 0 |
Dermira Inc | COMM | 24983L104 | 587 | 81,685 | SH | | SOLE | | 81,685 | 0 | 0 |
Epizyme Inc | COMM | 29428V104 | 519 | 84,246 | SH | | SOLE | | 84,246 | 0 | 0 |
Fate Therapeutics Inc | COMM | 31189P102 | 444 | 34,621 | SH | | SOLE | | 34,621 | 0 | 0 |
FibroGen Inc | COMM | 31572Q808 | 558 | 12,051 | SH | | SOLE | | 12,051 | 0 | 0 |
Five Prime Therapeutics Inc | COMM | 33830X104 | 442 | 47,504 | SH | | SOLE | | 47,504 | 0 | 0 |
Foamix Pharmaceuticals Ltd | COMM | M46135105 | 450 | 125,378 | SH | | SOLE | | 125,378 | 0 | 0 |
GW Pharmaceuticals PLC | ADR | 36197T103 | 440 | 4,519 | SH | | SOLE | | 4,519 | 0 | 0 |
Gilead Sciences Inc | COMM | 375558103 | 2,011 | 32,156 | SH | | SOLE | | 32,156 | 0 | 0 |
Heron Therapeutics Inc | COMM | 427746102 | 1,406 | 54,197 | SH | | SOLE | | 54,197 | 0 | 0 |
ImmunoGen Inc | COMM | 45253H101 | 323 | 67,348 | SH | | SOLE | | 67,348 | 0 | 0 |
Incyte Corp | COMM | 45337C102 | 1,806 | 28,396 | SH | | SOLE | | 28,396 | 0 | 0 |
Intercept Pharmaceuticals Inc | COMM | 45845P108 | 827 | 8,201 | SH | | SOLE | | 8,201 | 0 | 0 |
Kadmon Holdings Inc | COMM | 48283N106 | 510 | 244,958 | SH | | SOLE | | 244,958 | 0 | 0 |
Kala Pharmaceuticals Inc | COMM | 483119103 | 320 | 65,517 | SH | | SOLE | | 65,517 | 0 | 0 |
MacroGenics Inc | COMM | 556099109 | 637 | 50,152 | SH | | SOLE | | 50,152 | 0 | 0 |
MorphoSys AG | COMM | D55040105 | 1,237 | 12,126 | SH | | SOLE | | 12,126 | 0 | 0 |
Neurocrine Biosciences Inc | COMM | 64125C109 | 662 | 9,264 | SH | | SOLE | | 9,264 | 0 | 0 |
Orchard Therapeutics PLC | ADR | 68570P101 | 505 | 32,081 | SH | | SOLE | | 32,081 | 0 | 0 |
Osmotica Pharmaceuticals PLC | COMM | G6S41R101 | 286 | 36,901 | SH | | SOLE | | 36,901 | 0 | 0 |
Otonomy Inc | COMM | 68906L105 | 285 | 154,237 | SH | | SOLE | | 154,237 | 0 | 0 |
Pacira Pharmaceuticals Inc | COMM | 695127100 | 110 | 2,562 | SH | | SOLE | | 2,562 | 0 | 0 |
Puma Biotechnology Inc | COMM | 74587V107 | 584 | 28,693 | SH | | SOLE | | 28,693 | 0 | 0 |
Reata Pharmaceuticals Inc | COMM | 75615P103 | 1,336 | 23,813 | SH | | SOLE | | 23,813 | 0 | 0 |
Rigel Pharmaceuticals Inc | COMM | 766559603 | 1,168 | 508,013 | SH | | SOLE | | 508,013 | 0 | 0 |
Sanofi SA | ADR | 80105N105 | 2,141 | 49,315 | SH | | SOLE | | 49,315 | 0 | 0 |
Sarepta Therapeutics Inc | COMM | 803607100 | 804 | 7,363 | SH | | SOLE | | 7,363 | 0 | 0 |
Savara Inc | COMM | 805111101 | 852 | 112,569 | SH | | SOLE | | 112,569 | 0 | 0 |
Syndax Pharmaceuticals Inc | COMM | 87164F105 | 235 | 52,741 | SH | | SOLE | | 52,741 | 0 | 0 |
TESARO Inc | COMM | 881569107 | 1,491 | 20,083 | SH | | SOLE | | 20,083 | 0 | 0 |
Xencor Inc | COMM | 98401F105 | 1,088 | 30,080 | SH | | SOLE | | 30,080 | 0 | 0 |
Aimmune Therapeutics Inc | COMM | 00900T107 | 2,406 | 100,567 | SH | | OTR | 2 | 100,567 | 0 | 0 |
Amicus Therapeutics Inc | COMM | 03152W109 | 3,701 | 386,359 | SH | | OTR | 2 | 386,359 | 0 | 0 |
AnaptysBio Inc | COMM | 032724106 | 913 | 14,315 | SH | | OTR | 2 | 14,315 | 0 | 0 |
AstraZeneca PLC | ADR | 046353108 | 6,873 | 180,956 | SH | | OTR | 2 | 180,956 | 0 | 0 |
Biohaven Pharmaceutical Holding Company Ltd | COMM | G11196105 | 2,061 | 55,733 | SH | | OTR | 2 | 55,733 | 0 | 0 |
Biomarin Pharmaceutical Inc | COMM | 09061G101 | 6,846 | 80,397 | SH | | OTR | 2 | 80,397 | 0 | 0 |
Clovis Oncology Inc | COMM | 189464100 | 2,958 | 164,681 | SH | | OTR | 2 | 164,681 | 0 | 0 |
Conatus Pharmaceuticals Inc | COMM | 20600T108 | 632 | 365,126 | SH | | OTR | 2 | 365,126 | 0 | 0 |
Deciphera Pharmaceuticals Inc | COMM | 24344T101 | 3,188 | 151,881 | SH | | OTR | 2 | 151,881 | 0 | 0 |
Dermira Inc | COMM | 24983L104 | 2,231 | 310,232 | SH | | OTR | 2 | 310,232 | 0 | 0 |
Epizyme Inc | COMM | 29428V104 | 1,984 | 322,104 | SH | | OTR | 2 | 322,104 | 0 | 0 |
Fate Therapeutics Inc | COMM | 31189P102 | 1,687 | 131,478 | SH | | OTR | 2 | 131,478 | 0 | 0 |
FibroGen Inc | COMM | 31572Q808 | 2,118 | 45,769 | SH | | OTR | 2 | 45,769 | 0 | 0 |
Five Prime Therapeutics Inc | COMM | 33830X104 | 1,678 | 180,415 | SH | | OTR | 2 | 180,415 | 0 | 0 |
Foamix Pharmaceuticals Ltd | COMM | M46135105 | 1,709 | 476,173 | SH | | OTR | 2 | 476,173 | 0 | 0 |
GW Pharmaceuticals PLC | ADR | 36197T103 | 1,672 | 17,164 | SH | | OTR | 2 | 17,164 | 0 | 0 |
Gilead Sciences Inc | COMM | 375558103 | 7,633 | 122,036 | SH | | OTR | 2 | 122,036 | 0 | 0 |
Heron Therapeutics Inc | COMM | 427746102 | 5,338 | 205,779 | SH | | OTR | 2 | 205,779 | 0 | 0 |
ImmunoGen Inc | COMM | 45253H101 | 1,228 | 255,781 | SH | | OTR | 2 | 255,781 | 0 | 0 |
Incyte Corp | COMM | 45337C102 | 6,858 | 107,841 | SH | | OTR | 2 | 107,841 | 0 | 0 |
Intercept Pharmaceuticals Inc | COMM | 45845P108 | 3,139 | 31,145 | SH | | OTR | 2 | 31,145 | 0 | 0 |
Kadmon Holdings Inc | COMM | 48283N106 | 1,992 | 957,858 | SH | | OTR | 2 | 957,858 | 0 | 0 |
Kala Pharmaceuticals Inc | COMM | 483119103 | 1,232 | 252,044 | SH | | OTR | 2 | 252,044 | 0 | 0 |
MacroGenics Inc | COMM | 556099109 | 2,419 | 190,468 | SH | | OTR | 2 | 190,468 | 0 | 0 |
MorphoSys AG | COMM | D55040105 | 4,700 | 46,066 | SH | | OTR | 2 | 46,066 | 0 | 0 |
Neurocrine Biosciences Inc | COMM | 64125C109 | 2,513 | 35,185 | SH | | OTR | 2 | 35,185 | 0 | 0 |
Orchard Therapeutics PLC | ADR | 68570P101 | 1,944 | 123,580 | SH | | OTR | 2 | 123,580 | 0 | 0 |
Osmotica Pharmaceuticals PLC | COMM | G6S41R101 | 1,094 | 141,191 | SH | | OTR | 2 | 141,191 | 0 | 0 |
Otonomy Inc | COMM | 68906L105 | 1,084 | 585,775 | SH | | OTR | 2 | 585,775 | 0 | 0 |
Pacira Pharmaceuticals Inc | COMM | 695127100 | 418 | 9,721 | SH | | OTR | 2 | 9,721 | 0 | 0 |
Puma Biotechnology Inc | COMM | 74587V107 | 2,219 | 109,058 | SH | | OTR | 2 | 109,058 | 0 | 0 |
Reata Pharmaceuticals Inc | COMM | 75615P103 | 5,069 | 90,354 | SH | | OTR | 2 | 90,354 | 0 | 0 |
Rigel Pharmaceuticals Inc | COMM | 766559603 | 4,439 | 1,930,092 | SH | | OTR | 2 | 1,930,092 | 0 | 0 |
Sanofi SA | ADR | 80105N105 | 8,125 | 187,162 | SH | | OTR | 2 | 187,162 | 0 | 0 |
Sarepta Therapeutics Inc | COMM | 803607100 | 3,053 | 27,973 | SH | | OTR | 2 | 27,973 | 0 | 0 |
Savara Inc | COMM | 805111101 | 3,241 | 428,087 | SH | | OTR | 2 | 428,087 | 0 | 0 |
Syndax Pharmaceuticals Inc | COMM | 87164F105 | 891 | 200,306 | SH | | OTR | 2 | 200,306 | 0 | 0 |
TESARO Inc | COMM | 881569107 | 5,747 | 77,403 | SH | | OTR | 2 | 77,403 | 0 | 0 |
Xencor Inc | COMM | 98401F105 | 4,131 | 114,239 | SH | | OTR | 2 | 114,239 | 0 | 0 |
Aimmune Therapeutics Inc | COMM | 00900T107 | 1,166 | 48,741 | SH | | OTR | 1 | 48,741 | 0 | 0 |
Amicus Therapeutics Inc | COMM | 03152W109 | 1,789 | 186,772 | SH | | OTR | 1 | 186,772 | 0 | 0 |
AnaptysBio Inc | COMM | 032724106 | 442 | 6,936 | SH | | OTR | 1 | 6,936 | 0 | 0 |
AstraZeneca PLC | ADR | 046353108 | 3,331 | 87,691 | SH | | OTR | 1 | 87,691 | 0 | 0 |
Biohaven Pharmaceutical Holding Company Ltd | COMM | G11196105 | 1,000 | 27,039 | SH | | OTR | 1 | 27,039 | 0 | 0 |
Biomarin Pharmaceutical Inc | COMM | 09061G101 | 3,318 | 38,961 | SH | | OTR | 1 | 38,961 | 0 | 0 |
Clovis Oncology Inc | COMM | 189464100 | 1,432 | 79,746 | SH | | OTR | 1 | 79,746 | 0 | 0 |
Conatus Pharmaceuticals Inc | COMM | 20600T108 | 306 | 176,932 | SH | | OTR | 1 | 176,932 | 0 | 0 |
Deciphera Pharmaceuticals Inc | COMM | 24344T101 | 1,545 | 73,602 | SH | | OTR | 1 | 73,602 | 0 | 0 |
Dermira Inc | COMM | 24983L104 | 1,081 | 150,307 | SH | | OTR | 1 | 150,307 | 0 | 0 |
Epizyme Inc | COMM | 29428V104 | 969 | 157,305 | SH | | OTR | 1 | 157,305 | 0 | 0 |
Fate Therapeutics Inc | COMM | 31189P102 | 817 | 63,714 | SH | | OTR | 1 | 63,714 | 0 | 0 |
FibroGen Inc | COMM | 31572Q808 | 1,026 | 22,180 | SH | | OTR | 1 | 22,180 | 0 | 0 |
Five Prime Therapeutics Inc | COMM | 33830X104 | 813 | 87,425 | SH | | OTR | 1 | 87,425 | 0 | 0 |
Foamix Pharmaceuticals Ltd | COMM | M46135105 | 828 | 230,742 | SH | | OTR | 1 | 230,742 | 0 | 0 |
GW Pharmaceuticals PLC | ADR | 36197T103 | 810 | 8,317 | SH | | OTR | 1 | 8,317 | 0 | 0 |
Gilead Sciences Inc | COMM | 375558103 | 3,699 | 59,139 | SH | | OTR | 1 | 59,139 | 0 | 0 |
Heron Therapeutics Inc | COMM | 427746102 | 2,587 | 99,737 | SH | | OTR | 1 | 99,737 | 0 | 0 |
ImmunoGen Inc | COMM | 45253H101 | 595 | 123,946 | SH | | OTR | 1 | 123,946 | 0 | 0 |
Incyte Corp | COMM | 45337C102 | 3,323 | 52,260 | SH | | OTR | 1 | 52,260 | 0 | 0 |
Intercept Pharmaceuticals Inc | COMM | 45845P108 | 1,525 | 15,126 | SH | | OTR | 1 | 15,126 | 0 | 0 |
Kadmon Holdings Inc | COMM | 48283N106 | 933 | 448,356 | SH | | OTR | 1 | 448,356 | 0 | 0 |
Kala Pharmaceuticals Inc | COMM | 483119103 | 626 | 127,955 | SH | | OTR | 1 | 127,955 | 0 | 0 |
MacroGenics Inc | COMM | 556099109 | 1,172 | 92,301 | SH | | OTR | 1 | 92,301 | 0 | 0 |
MorphoSys AG | COMM | D55040105 | 2,280 | 22,344 | SH | | OTR | 1 | 22,344 | 0 | 0 |
Neurocrine Biosciences Inc | COMM | 64125C109 | 1,218 | 17,051 | SH | | OTR | 1 | 17,051 | 0 | 0 |
Orchard Therapeutics PLC | ADR | 68570P101 | 1,053 | 66,957 | SH | | OTR | 1 | 66,957 | 0 | 0 |
Osmotica Pharmaceuticals PLC | COMM | G6S41R101 | 581 | 74,997 | SH | | OTR | 1 | 74,997 | 0 | 0 |
Otonomy Inc | COMM | 68906L105 | 525 | 283,853 | SH | | OTR | 1 | 283,853 | 0 | 0 |
Pacira Pharmaceuticals Inc | COMM | 695127100 | 203 | 4,711 | SH | | OTR | 1 | 4,711 | 0 | 0 |
Puma Biotechnology Inc | COMM | 74587V107 | 1,076 | 52,876 | SH | | OTR | 1 | 52,876 | 0 | 0 |
Reata Pharmaceuticals Inc | COMM | 75615P103 | 2,458 | 43,817 | SH | | OTR | 1 | 43,817 | 0 | 0 |
Rigel Pharmaceuticals Inc | COMM | 766559603 | 2,171 | 944,069 | SH | | OTR | 1 | 944,069 | 0 | 0 |
Sanofi SA | ADR | 80105N105 | 3,937 | 90,698 | SH | | OTR | 1 | 90,698 | 0 | 0 |
Sarepta Therapeutics Inc | COMM | 803607100 | 1,480 | 13,558 | SH | | OTR | 1 | 13,558 | 0 | 0 |
Savara Inc | COMM | 805111101 | 1,618 | 213,716 | SH | | OTR | 1 | 213,716 | 0 | 0 |
Syndax Pharmaceuticals Inc | COMM | 87164F105 | 432 | 97,063 | SH | | OTR | 1 | 97,063 | 0 | 0 |
TESARO Inc | COMM | 881569107 | 2,733 | 36,811 | SH | | OTR | 1 | 36,811 | 0 | 0 |
Xencor Inc | COMM | 98401F105 | 2,002 | 55,363 | SH | | OTR | 1 | 55,363 | 0 | 0 |